SUBSCRIBE
SUBSCRIBE

Patient recruitment

PRESS RELEASES
Press Releases
Pasithea Therapeutics Announces Completion of Enrollment and Initial Dosing of Patients in Cohort 6 from its Phase 1 Trial of PAS-004 in Advanced Cancer Patients
April 30, 2025
 · 
3 min read
Press Releases
Alcresta Therapeutics Announces Enrollment of First Patient in Clinical Trial Evaluating Use of RELiZORB in Pancreatitis Patients at Massachusetts General Hospital
April 30, 2025
 · 
3 min read
Press Releases
Kura Oncology Announces First Patients Dosed in Phase 1 Combination Trial of Ziftomenib for the Treatment of Advanced GIST
April 29, 2025
 · 
8 min read
Press Releases
Levee Medical® Announces First Patient Enrolled in ARID II IDE Pivotal Trial
April 25, 2025
 · 
1 min read
Press Releases
Zealand Pharma announces first participant enrolled in Phase 2b ZUPREME-2 trial of petrelintide in people with overweight or obesity and type 2 diabetes
April 24, 2025
 · 
8 min read
Press Releases
March Biosciences Announces First Patient Dosed in Phase 2 Clinical Trial of MB-105, First-in-Class CD5 CAR-T Cell Therapy for T-Cell Lymphoma
April 23, 2025
 · 
4 min read
Press Releases
Carthera Reaches Recruitment Milestone in SONOBIRD Pivotal Trial for Recurrent Glioblastoma
April 22, 2025
 · 
5 min read
Press Releases
OM1 Adds 1 Million Patients to Its Mental Health Network, Significantly Expanding Specialty Coverage and Driving New Possibilities for Real-World Research and Personalized Care
April 22, 2025
 · 
2 min read
Press Releases
Arch Biopartners Announces Toronto General Hospital Ethics Board Approval to Join the Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury (CS-AKI)
April 22, 2025
 · 
5 min read
Press Releases
NexThera Completes First Patient Enrollment in U.S. Clinical Trial for ‘NT-101,’ an Eye Drop Treatment for Wet AMD
April 9, 2025
 · 
2 min read
Press Releases
First Patient Enrolled in NIH-Funded Expanded Access Program (EAP) Trial to Evaluate MN-166 in Amyotrophic Lateral Sclerosis (ALS) Patients
April 9, 2025
 · 
5 min read
Press Releases
Pacira BioSciences Announces First Patient Dosed in Phase 2 Study Evaluating Safety and Efficacy of PCRX-201 for the Treatment of Osteoarthritis of the Knee
April 4, 2025
 · 
11 min read
Press Releases
Anaconda Biomed Enrolls First U.S. Patient in the ATHENA Clinical Trial Evaluating ANA Funnel Catheter for Ischemic Stroke Treatment
April 3, 2025
 · 
3 min read
Press Releases
Nexalin Technology Enrolls First Patients and Advances Toward Treatment in UCSD Clinical Trial
April 3, 2025
 · 
4 min read
Press Releases
Jabez Biosciences, Inc. Announces First Patient Dosed in Phase 1 Oncology Clinical Study of JBZ-001
April 3, 2025
 · 
3 min read
Press Releases
Mainz Biomed Enrolls First Patient in Its eAArly DETECT 2 Clinical Study
March 28, 2025
 · 
4 min read
Press Releases
Yoda Therapeutics Announces First Patient Dosed in Phase 2 Trial of YA-101 for Multiple System Atrophy
March 27, 2025
 · 
3 min read
Press Releases
Bluejay Therapeutics Announces First Patient Dosed in AZURE-1 Global Pivotal Clinical Trial Evaluating Brelovitug (BJT-778) as a Monotherapy Treatment for Chronic Hepatitis D
March 27, 2025
 · 
3 min read
Press Releases
Innovent Dosed First Participant in Phase 3 Clinical Study of IBI354 (Novel HER2 ADC) for Platinum-resistant Ovarian Cancer
March 24, 2025
 · 
10 min read
Press Releases
Pharming Group announces first patient dosed in Phase II clinical trial of leniolisib for common variable immunodeficiency (CVID) with immune dysregulation
March 20, 2025
 · 
8 min read
Load More